Antipsychotics: Neuroleptic malignant syndrome (first report with perospirone): 2 case reports

Author：

ISSN： 0114-9954

Source： Reactions Weekly, Vol.1, Iss.1074, 2005-01, pp. : 6-6

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Perospirone: Neuroleptic malignant syndrome: case report

Reactions Weekly, Vol. 1, Iss. 1131, 2006-01 ,pp. : 28-29

Adis International

Access to resources Recommend Favorite

Antipsychotics: Neuroleptic malignant syndrome: 3 case reports

Reactions Weekly, Vol. 1, Iss. 1420, 2012-01 ,pp. : 9-10

Adis International

Access to resources Recommend Favorite

Antipsychotics: Neuroleptic malignant syndrome: 18 case reports

Reactions Weekly, Vol. 1, Iss. 1386, 2012-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite

Antipsychotics/scopolamine hydrobromide: Neuroleptic malignant syndrome (first report with scopolamine): case report

Reactions Weekly, Vol. 1, Iss. 1386, 2012-01 ,pp. : 8-9

Adis International

Access to resources Recommend Favorite

Scopolamine hydrobromide/antipsychotics: Neuroleptic malignant syndrome (first report with scopolamine hydrobromide): case report

Reactions Weekly, Vol. 1, Iss. 1377, 2011-01 ,pp. : 34-35

Adis International

Access to resources Recommend Favorite